UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (Date of earliest event reported): May 22, 2012
IGI LABORATORIES, INC.
(Exact name of registrant as specified in charter)
DELAWARE | 001-08568 | 01-0355758 |
(State or Other Jurisdiction of | (Commission | (I.R.S. Employer |
105 Lincoln Avenue
Buena, New Jersey 08310
(Address of principal executive offices)(Zip Code)
(856) 697-1441
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
[ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
[ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
|
|
[ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
Item 5.07. Submission of Matters to a Vote of Security Holders.
On May 22, 2012, the Company held its Annual Meeting of Stockholders. At the Annual Meeting, 35,888,534 votes were present in person or by proxy, which represented 84.5% of the total outstanding eligible votes as of the record date of April 25, 2012. Two proposals were before the meeting: (1) the election of six directors to serve until the next Annual Meeting of Stockholders and until their respective successors have been elected and qualified and (2) the ratification of the appointment of EisnerAmper LLP as the Company’s independent registered public accounting firm for 2012.
Both of the proposals were approved. The votes with respect to the proposals are set forth below.
(1)
Elect six directors to serve until the next Annual Meeting of Stockholders:
Name of Director |
|
|
|
|
|
James C. Gale | 17,104,880 | 121,689 |
|
|
|
Narendra N. Borkar | 17,116,780 | 109,789 |
|
|
|
Michael Hemric | 17,104,215 | 122,354 |
|
|
|
Charles Moore | 17,033,580 | 192,989 |
|
|
|
Joyce Erony | 17,073,882 | 152,687 |
|
|
|
Bhaskar Chaudhuri | 17,099,165 | 127,404 |
(2)
Ratify the appointment of EisnerAmper LLP as the Company’s independent registered public accounting firm for 2012:
Votes For | Votes Against | Votes Abstain |
|
|
|
35,539,267 | 65,167 | 4,107 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| IGI LABORATORIES, INC. |
|
|
Date: May 25, 2012 | By: /s/Jenniffer Collins |
| Name: Jenniffer Collins |
| Title: Chief Financial Officer |